NCT02884791View on ClinicalTrials.gov

FGF21 and Fructose Challenge in Humans

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions
Fasting
Interventions
DIETARY_SUPPLEMENT

oral carbohydrate challenge

Participants will fast for 8 hours and then drink a beverage containing fructose.

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT02884791 - FGF21 and Fructose Challenge in Humans | Biotech Hunter | Biotech Hunter